Hyperfine, Inc. (NASDAQ:HYPR) Receives Consensus Recommendation of “Hold” from Analysts

Shares of Hyperfine, Inc. (NASDAQ:HYPR) have been assigned an average rating of “Hold” from the six research firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and three have issued a buy recommendation on the company. The average 1-year price target among brokerages that have issued a report on the stock in the last year is $1.7833.

A number of brokerages recently issued reports on HYPR. B. Riley Financial reiterated a “buy” rating on shares of Hyperfine in a report on Wednesday, May 13th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Hyperfine in a report on Tuesday, April 21st. Lake Street Capital increased their target price on Hyperfine from $2.00 to $2.50 and gave the stock a “buy” rating in a report on Thursday, March 19th. BTIG Research began coverage on Hyperfine in a report on Wednesday, April 29th. They issued a “buy” rating and a $2.00 target price on the stock. Finally, Zacks Research upgraded Hyperfine to a “hold” rating in a report on Thursday, March 19th.

Hyperfine Price Performance

Shares of HYPR opened at $1.48 on Monday. Hyperfine has a 12-month low of $0.68 and a 12-month high of $2.22. The business’s fifty day moving average is $1.49 and its 200 day moving average is $1.25. The company has a quick ratio of 4.90, a current ratio of 5.52 and a debt-to-equity ratio of 0.38. The stock has a market cap of $146.42 million, a P/E ratio of -3.60 and a beta of 1.38.

Hyperfine (NASDAQ:HYPR) last issued its earnings results on Tuesday, May 12th. The company reported ($0.09) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.09). Hyperfine had a negative return on equity of 98.83% and a negative net margin of 226.88%.The company had revenue of $3.90 million for the quarter, compared to analysts’ expectations of $3.54 million. Sell-side analysts anticipate that Hyperfine will post -0.34 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Hyperfine

Institutional investors and hedge funds have recently bought and sold shares of the stock. EP Wealth Advisors LLC purchased a new stake in Hyperfine in the 4th quarter valued at $34,000. Sanctuary Advisors LLC raised its position in Hyperfine by 130.9% in the 4th quarter. Sanctuary Advisors LLC now owns 39,938 shares of the company’s stock valued at $39,000 after buying an additional 22,638 shares during the last quarter. Tortoise Investment Management LLC purchased a new stake in Hyperfine in the 3rd quarter valued at $65,000. Kathmere Capital Management LLC purchased a new stake in Hyperfine in the 4th quarter valued at $51,000. Finally, Millennium Management LLC purchased a new stake in Hyperfine in the 4th quarter valued at $55,000. 15.03% of the stock is owned by hedge funds and other institutional investors.

About Hyperfine

Hyperfine, Inc (NASDAQ: HYPR) is a medical technology company focused on expanding access to advanced neuroimaging through its portable magnetic resonance imaging (MRI) system. The company’s flagship product, Swoop®, is designed to enable bedside MRI scanning in a wide range of clinical environments, including emergency departments, intensive care units and outpatient clinics. By leveraging a compact, high-performance permanent magnet and a custom-designed gradient system, Hyperfine aims to reduce the logistical and financial barriers associated with traditional, large-scale MRI installations.

The Swoop system features a lightweight, wheeled design that can be maneuvered directly to a patient’s bedside, allowing clinicians to conduct diagnostic imaging without the need to transport critically ill or immobile patients.